Oral tranexamic acid for acute management of active bleeding from iris microhemangiomatosis: A case report

Am J Ophthalmol Case Rep. 2024 Jan 19:33:102000. doi: 10.1016/j.ajoc.2024.102000. eCollection 2024 Mar.

Abstract

Purpose: to report a case of active intraocular bleeding caused by iris microhemangiomatosis managed with oral tranexamic acid.

Observations: an 80-year-old male was referred to our emergency department for acute intraocular bleeding. Eye exam showed filiform bleeding arising from a cluster of vascular tufts at the upper pupillary margin, which was consistent with a diagnosis of iris microhemangiomatosis. The bleeding had started 6 hours before and could not be halted by conservative maneuvers such as ocular compression and application of sympathomimetic drops. Oral tranexamic acid 500 mg was administered and led to prompt resolution of the hemorrhage within 60 minutes. The patient was monitored for 3 months and showed no recurrence of the hemorrhage.

Conclusion and importance: oral tranexamic acid may represent a viable option to manage active intraocular bleeding from iris microhemangiomatosis, facilitating rapid hemorrhage resolution.

Keywords: Intraocular bleeding; Iris microhemangiomatosis; Tranexamic acid.

Publication types

  • Case Reports